These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11680728)

  • 1. Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigation.
    Koster A; Kukucka M; Fischer T; Hetzer R; Kuppe H
    J Extra Corpor Technol; 2001 Sep; 33(3):153-8. PubMed ID: 11680728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography.
    Miller BE; Guzzetta NA; Tosone SR; Levy JH
    Anesth Analg; 2000 Jun; 90(6):1324-30. PubMed ID: 10825314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the resonance thromboelastograph CS-3 for differentiation of coagulation disorders: a pilot in vitro investigation of simulated post-cardiopulmonary bypass coagulopathies.
    Koster A; Hansen R; Schulz J; Kukucka M; Fischer T; Kuppe H
    J Extra Corpor Technol; 2001 Sep; 33(3):159-66. PubMed ID: 11680729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
    Gertler R; Wiesner G; Tassani-Prell P; Braun SL; Martin K
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
    Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
    Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397).
    Petricevic M; Biocina B; Milicic D; Svetina L; Boban M; Lekić A; Konosic S; Milosevic M; Gasparovic H
    J Cardiothorac Surg; 2014 Sep; 9():129. PubMed ID: 25231271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
    Willems A; Savan V; Faraoni D; De Ville A; Rozen L; Demulder A; Van der Linden P
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1184-9. PubMed ID: 27461795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass.
    Zisman E; Eden A; Shenderey A; Meyer G; Balagula M; Ammar R; Pizov R
    Eur J Anaesthesiol; 2009 Oct; 26(10):868-73. PubMed ID: 19528806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study.
    Gronchi F; Perret A; Ferrari E; Marcucci CM; Flèche J; Crosset M; Schoettker P; Marcucci C
    Eur J Anaesthesiol; 2014 Feb; 31(2):68-75. PubMed ID: 23867776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies.
    Spiess BD; Tuman KJ; McCarthy RJ; DeLaria GA; Schillo R; Ivankovich AD
    J Clin Monit; 1987 Jan; 3(1):25-30. PubMed ID: 3819793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass.
    Royston D; von Kier S
    Br J Anaesth; 2001 Apr; 86(4):575-8. PubMed ID: 11573637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of heparinase modified thrombelastography in liver transplantation.
    Harding SA; Mallett SV; Peachey TD; Cox DJ
    Br J Anaesth; 1997 Feb; 78(2):175-9. PubMed ID: 9068337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
    Miles LF; Marchiori P; Falter F
    Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.